Alaven Pharmaceutical

Alaven Pharmaceutical, located in Atlanta, Georgia was formed in 2003 to license, acquire, develop and market niche pharmaceutical products.

In April 2006, Greyrock Capital provided $2.00 million of subordinated debt and a $3.00 million equity co-investment to support Alaven’s acquisition of three niche pharmaceutical products.